Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Reveal the Neutrophil: Elucidating the Role of a Neutrophil-Specific JAK2-V617F Mutation

Tobias Ronny Haage, MD, Andreas Johann Müller, Priyadharshini Arunachalam, Thomas Fischer, MD

Blood (2019) 134 (Supplement_1): 2965.

https://doi.org/10.1182/blood-2019-122660

Published: 2019

Journal Articles

Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic

Zuzana Vrzalova, PhD, Hana Jelinkova, Stepan Hrabovsky, Frantisek Folber, MD PhD, Cyril Salek, Jan Horacek, Marketa Zaliova, Jiri Stika, Martina Slavikova, Sarka Pospisilova, Michael Doubek, MD PhD

Blood (2018) 132 (Supplement 1): 4090.

https://doi.org/10.1182/blood-2018-99-118308

Published: 2018

Journal Articles

Genomic and Outcome Analyses of Philadelphia Chromosome-like (Ph-like) NCI Standard Risk B-Acute Lymphoblastic Leukemia (SR B-ALL) Patients Treated on Children's Oncology Group (COG) AALL0331

Blood (2017) 130 (Supplement 1): 477.

https://doi.org/10.1182/blood.V130.Suppl_1.477.477

Published: 2017

Journal Articles

Gene-Drug Interactions in AML Patients Identified By RNA Sequencing and Comprehensive Ex Vivo Drug Sensitivity and Resistance Testing

Ashwini Kumar, MRes, Dishaben Rameshbhai Malani, MSc, Bhagwan Yadav, PhD, Matti Kankainen, PhD, Swapnil Potdar, MSc, Mika Kontro, MD, Kimmo Porkka, MD PhD, Olli Kallioniemi, MD PhD, Simon Anders, PhD, Caroline A Heckman, PhD

Blood (2017) 130 (Supplement 1): 1398.

https://doi.org/10.1182/blood.V130.Suppl_1.1398.1398

Published: 2017

Journal Articles

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

Paolo Bernasconi, MD, Irene Dambruoso, Marina Boni, Paola Maria Cavigliano, Ilaria Giardini, Barbara Rocca, Rita Zappatore, Marilena Caresana, Antonella Orlando, Ilaria Casetti, MD, Chiara Elena, MD, Elisa Rumi, MD, Mario Cazzola, MD

Blood (2016) 128 (22): 5493.

https://doi.org/10.1182/blood.V128.22.5493.5493

Published: 2016

Journal Articles

JAK2V617F Clonal Architecture in MPNs during JAK2 Inhibitor Treatment

Annalisa Pacilli, PhD, Paola Guglielmelli, MD PhD, Tiziana Fanelli, MSc, Alessandro Pancrazzi, BS, Lisa Pieri, MD PhD, Rajmonda Fjerza, MD, Alessandro M. Vannucchi

Blood (2015) 126 (23): 1630.

https://doi.org/10.1182/blood.V126.23.1630.1630

Published: 2015

Journal Articles

Comprehensive Analysis of JAK2 Mutations: A Single Center Experience

Nahlah AlGhasham, MD, Yasmeen Alnouri, MD, Halah Abalkhail, PhD, Salem Khalil, MD

Blood (2014) 124 (21): 5568.

https://doi.org/10.1182/blood.V124.21.5568.5568

Published: 2014

Journal Articles

Impact of the JAK2V617F Mutation on the Hemato-Endothelial Differentiation in an Induced Pluripotent Stem Cells (iPSC) Model

Elodie Lesteven, PharmD, PhD, Doriane Pognant, Valerie Vanneaux, PharmD, PhD, Jérome Larghero, PharmD, PhD, Olivier Feraud, Annelise Bennaceur-Griscelli, MD PhD, Emmanuelle Verger, PhD, Annalisa Andreoli, MD, Christine Chomienne, MD PhD, Bruno Cassinat, PharmD, PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2014) 124 (21): 4570.

https://doi.org/10.1182/blood.V124.21.4570.4570

Published: 2014

Journal Articles

Familiar JAK2 G571S Variant Not Linked with Essential Trombocythemia

Irina Panovska-Stavridis, MD PhD, Aleksandar Eftimov, Mr.Sci, Aleksandra Pivkova-Veljanovska, MDPhD, Martin Ivanovski, MD, Lidija Cevreska, MDPhD, Aleksandar J Dimovski, MDPhD

Blood (2014) 124 (21): 5585.

https://doi.org/10.1182/blood.V124.21.5585.5585

Published: 2014

Journal Articles

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

Lasse Kjaer, Ph.D., Eric Lippert, Francois Girodon, MD, PhD, Susanne Schnittger, PhD, Serge Carillo, Caroline Riley, MD, Beatriz Bellosillo, Maj K. Westman, Ole Weis Bjerrum, MD, Marzena Wojtaszewska, Thomas Kristensen, MSc, PhD, Melanie Percy, PhD, Mary Frances McMullin, MD, MRCPath, Maruska Marusic, Caroline Rosmond, Lars Palmqvist, MD, PhD, Sylvie Hermouet, MD, Ph.D., Hans Carl Hasselbalch, MD, DMSc

Blood (2013) 122 (21): 4075.

https://doi.org/10.1182/blood.V122.21.4075.4075

Published: 2013

Journal Articles

A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene

Nakhle Saba, Hana Safah

Blood (2013) 122 (6): 861.

https://doi.org/10.1182/blood-2013-03-487348

Published: 2013

Journal Articles

46/1 Haplotype Permits to Follow JAK2 Homologous Recombination: Modeling JAK2 V617F clonal Architecture in PV Patients

Salma Hasan, PhD Student, Jean Pierre Le Couedic, Fabrizia Favale, Barbara Monte-Mor, Catherine Lacout, Nicole Casadevall, MD, Eric Solary, Jean-Luc Villeval, PhD, Isabelle Plo, Ph.D, William Vainchenker, MD, PhD

Blood (2012) 120 (21): 1757.

https://doi.org/10.1182/blood.V120.21.1757.1757

Published: 2012

Journal Articles

Design and Application of a Novel PNA Probe for the Detection At Single Cell Level of JAK2 V617F Mutation

Daniela Cilloni, MD, Valentina Rosso, PhD, Davide Torti, MD, Francesca Carnuccio, PhD, Anna Serra, PhD, Paolo Nicoli, MD, Valentina Gaidano, MD, Valentina Campia, PhD, Elisabetta Signorino, PhD, Chiara Calabrese, PhD, Sonia Carturan, PhD, Alessandra Favole, PhD, Giuseppe Saglio, MD, Francesco Frassoni, Enrico Bracco, PhD

Blood (2012) 120 (21): 1761.

https://doi.org/10.1182/blood.V120.21.1761.1761

Published: 2012

Journal Articles

Incidence of the JAK2 V617F Mutation In Mexican Patients with Myeloproliferative Neoplasms (MPNs)

Gregorio Ignacio, MD, Rosa María Arana-Trejo, MD, Verónica Gónzalez, QFB, Maria Paula Hérnandez, MD, Yolanda Lugo, Dr, Luis Solis, Dr, Jesús Castellanos, Dr, Samuel Celestino, Dr, Carlos Váldez, Dr, Ramón Rivas, Dr

Blood (2011) 118 (21): 5180.

https://doi.org/10.1182/blood.V118.21.5180.5180

Published: 2011

Journal Articles

JAK1 and JAK2 Modulate Myeloma Cell Susceptibility to NK Cells Through the Interferon Gamma (IFN-γ) Pathway,

Roberto Bellucci, PhD, Allison Martin, BS, Marc Buren, Hong-Nam Nguyen, BS, Davide Bommarito, Jerome Ritz, MD

Blood (2011) 118 (21): 3960.

https://doi.org/10.1182/blood.V118.21.3960.3960

Published: 2011

Journal Articles

Analysis of the JAK2 Gene cDNA Full-Length In One Chinese Familial Myeloproliferative Disorders

Ru Feng, M.D., Lixia Hao, Yongmin Zhang, Yongqiang Wei, Fen Huang, Changxin Yin

Blood (2010) 116 (21): 5056.

https://doi.org/10.1182/blood.V116.21.5056.5056

Published: 2010

Journal Articles

The JAK2V617F Mutation In Non-MPD Individuals Occurs at a Low Frequency During Erythroid Differentiation and Not In the Stem Cells.

Svetlana Krichevsky, Ariel Borohovitz, Jenny Prus, Riki Perlman, Ido Weinberg, Julia Abramowitz, Aliza Treves, Eitan Fibach, PhD, Dina Ben-Yehuda

Blood (2010) 116 (21): 1583.

https://doi.org/10.1182/blood.V116.21.1583.1583

Published: 2010

Journal Articles

The Analysis of JAK2 and MPL Mutation as Well as JAK2 SNPs in MPN Patients by MassARRAY Assay.

Su-Jiang Zhang, Hongxia Qiu, Jianyong Li, MD, PhD

Blood (2009) 114 (22): 4989.

https://doi.org/10.1182/blood.V114.22.4989.4989

Published: 2009

Journal Articles

Physiological Levels of Jak2 V617F Result in Enhanced Megakaryocyte Differentiation, Proplatelet Formation and Platelet Reactivity.

Cedric J Ghevaert, MD, PhD, Juan Li, PhD, Sonia Severin, PhD, Jocelyn Auger, PhD, Steve Watson, BSc, PhD, Anthony R. Green, FRCP, FRCPath, FMed, Sci

Blood (2009) 114 (22): 226.

https://doi.org/10.1182/blood.V114.22.226.226

Published: 2009

Journal Articles

Same mutation, different allele

Karl J. Aichberger, Angela G. Fleischman, Michael W. Deininger

Blood (2009) 114 (14): 2853–2854.

https://doi.org/10.1182/blood-2009-07-229906

Published: 2009

NARROW

Reveal the Neutrophil: Elucidating the Role of a Neutrophil-Specific JAK2-V617F Mutation

Gene Aberrations in Adult Patients with Ph-Negative ALL in the Czech Republic

Genomic and Outcome Analyses of Philadelphia Chromosome-like (Ph-like) NCI Standard Risk B-Acute Lymphoblastic Leukemia (SR B-ALL) Patients Treated on Children's Oncology Group (COG) AALL0331

Gene-Drug Interactions in AML Patients Identified By RNA Sequencing and Comprehensive Ex Vivo Drug Sensitivity and Resistance Testing

Rearrangements of Tyrosine Kinase (TK) Genes in Chronic Myeloproliferative Disorders (CMPD): A FISH Study

JAK2V617F Clonal Architecture in MPNs during JAK2 Inhibitor Treatment

Comprehensive Analysis of JAK2 Mutations: A Single Center Experience

Impact of the JAK2V617F Mutation on the Hemato-Endothelial Differentiation in an Induced Pluripotent Stem Cells (iPSC) Model

Familiar JAK2 G571S Variant Not Linked with Essential Trombocythemia

JAK2 Exon 12 Mutant Allele Burden Study (JETMABS): A European Multicenter Study

A myeloproliferative neoplasm with translocation t(8;9)(p22;p24) involving JAK2 gene

46/1 Haplotype Permits to Follow JAK2 Homologous Recombination: Modeling JAK2 V617F clonal Architecture in PV Patients

Design and Application of a Novel PNA Probe for the Detection At Single Cell Level of JAK2 V617F Mutation

Incidence of the JAK2 V617F Mutation In Mexican Patients with Myeloproliferative Neoplasms (MPNs)

JAK1 and JAK2 Modulate Myeloma Cell Susceptibility to NK Cells Through the Interferon Gamma (IFN-γ) Pathway,

Analysis of the JAK2 Gene cDNA Full-Length In One Chinese Familial Myeloproliferative Disorders

The JAK2V617F Mutation In Non-MPD Individuals Occurs at a Low Frequency During Erythroid Differentiation and Not In the Stem Cells.

The Analysis of JAK2 and MPL Mutation as Well as JAK2 SNPs in MPN Patients by MassARRAY Assay.

Physiological Levels of Jak2 V617F Result in Enhanced Megakaryocyte Differentiation, Proplatelet Formation and Platelet Reactivity.

Same mutation, different allele

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only